EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The rewiring of cAMP/cGMP and LDH signalling drives cardiac hypertrophy in Pde5a −/− mice

Ana Gabriela de Oliveira do Rêgo iD, Sonia Maccari iD, Giuseppe Marano iD, Tonino Stati, Michele Saliola, Mauro Giorgi, Silvia Cardarelli, Matilde Merolle iD, Francesco Tomassoni-Ardori, Lino Tessarollo, Federica Campolo, Andrea M Isidori iD und 4 weitere

Life Science Alliance · 2025

DOI: 10.26508/lsa.202403094 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Life Science Alliance, 2025. Verfasst von Ana Gabriela de Oliveira do Rêgo und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomical, Histological, Forensic and Orthopaedic Sciences, Sapienza University of Rome, Rome, Italy. Hauptthemen laut MEDLINE: Cyclic Nucleotide Phosphodiesterases, Type 5, Cardiomegaly, Cyclic GMP, Cyclic AMP. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Intramural Research Program of National Cancer Institute, NIH, Saving Tiny Hearts Society, Fondazione AIRC per la Ricerca sul Cancro ETS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Phosphodiesterase type 5a (Pde5a), an enzyme that hydrolyzes cGMP nucleotide, regulates several aspects of heart physiology and its inhibition improves left ventricular heart function under pathological conditions. We investigated Pde5a role in the development and progression of moderate and severe cardiac hypertrophy, induced by transverse aortic constriction (TAC), in Pde5a WT ( Pde5a +/+ ) and Pde5a-deficient ( Pde5a −/− ) mice. Cardiac hypertrophy was surprisingly detected in Pde5a −/− mice after TAC surgery with similar alterations of cardiac function, morphology, fibrosis, and expression of molecular markers compared with Pde5a +/+ mice. The Pde5a inhibitor, Sildenafil, prevented only moderate cardiac hypertrophy at the morpho-functional and molecular levels in Pde5a +/+ mice. Cardiac hypertrophy was found to be associated with unbalanced cAMP/cGMP ratio and lactate dehydrogenase plays a critical role in the metabolic remodelling of Pde5a −/− hearts under TAC conditions. In conclusion, pharmacological Pde5a inhibition counteracts moderate but not severe hypertrophy. Genetic ablation of Pde5a does not protect against moderate/severe cardiac hypertrophy. In the absence of Pde5a, the oxidative metabolism shifts towards a mixed oxidative-glycolytic metabolism under TAC condition.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cyclic Nucleotide Phosphodiesterases, Type 5CardiomegalyCyclic GMPCyclic AMPL-Lactate DehydrogenaseAnimalsMiceSignal TransductionMice, KnockoutMaleSildenafil CitratePhosphodiesterase 5 InhibitorsDisease Models, AnimalMice, Inbred C57BL

Substanzen

Cyclic Nucleotide Phosphodiesterases, Type 5Cyclic GMPPde5a protein, mouseCyclic AMPL-Lactate DehydrogenaseSildenafil CitratePhosphodiesterase 5 Inhibitors

Autor:innen und Institutionen

  • Department of Anatomical, Histological, Forensic and Orthopaedic Sciences, Sapienza University of Rome, Rome, Italy.
  • Institute of Biochemistry and Cell Biology, IBBC-CNR, Rome, Italy.
  • Center for Gender Medicine, Istituto Superiore di Sanità, Rome, Italy.
  • Department of Biology and Biotechnology "C. Darwin", Sapienza University, Rome, Italy.
  • Neural Development Section, Mouse Cancer Genetics Program, Center for Cancer Research, NCI, NIH, Frederick, MD, USA.
  • Department of Experimental Medicine, Sapienza University, Rome, Italy.

ORCID-Profile: Ana Gabriela de Oliveira do Rêgo, Sonia Maccari, Giuseppe Marano, Matilde Merolle, Andrea M Isidori, Fabio Naro, Manuela Pellegrini

Förderung

  • Intramural Research Program of National Cancer Institute, NIH
  • Saving Tiny Hearts Society
  • Fondazione AIRC per la Ricerca sul Cancro ETS
  • Sapienza University
  • National Cancer Center

Zitieren

APA

de Oliveira do Rêgo, A. G., Maccari, S., Marano, G., Stati, T., Saliola, M., Giorgi, M., Cardarelli, S., Merolle, M., Tomassoni-Ardori, F., Tessarollo, L., Campolo, F., Isidori, A. M., De Angelis, L., Naro, F., Monaco, L., & Pellegrini, M. (2025). The rewiring of cAMP/cGMP and LDH signalling drives cardiac hypertrophy in Pde5a −/− mice. Life Science Alliance. https://doi.org/10.26508/lsa.202403094

Vancouver

de Oliveira do Rêgo AG, Maccari S, Marano G, Stati T, Saliola M, Giorgi M, et al. The rewiring of cAMP/cGMP and LDH signalling drives cardiac hypertrophy in Pde5a −/− mice. Life Science Alliance. 2025. doi:10.26508/lsa.202403094

BibTeX
@article{deOliveiradoRgo2025,
  author = {de Oliveira do Rêgo, Ana Gabriela and Maccari, Sonia and Marano, Giuseppe and Stati, Tonino and Saliola, Michele and Giorgi, Mauro and Cardarelli, Silvia and Merolle, Matilde and Tomassoni-Ardori, Francesco and Tessarollo, Lino and Campolo, Federica and Isidori, Andrea M and De Angelis, Luciana and Naro, Fabio and Monaco, Lucia and Pellegrini, Manuela},
  title = {The rewiring of cAMP/cGMP and LDH signalling drives cardiac hypertrophy in Pde5a −/− mice},
  journal = {Life Science Alliance},
  year = {2025},
  doi = {10.26508/lsa.202403094}
}
Kostenlos starten →